Gene · 7030
Papers3,398
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,398
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Particle uptake by macrophages triggers bifurcated transcriptional pathways that differentially regulate inflammation and lysosomal gene expression. | Immunity | 2025 | 40118070 | PubTator, text mining | PubMed |
| [Clinicopathological features of primary pulmonary epithelioid hemangioendothelioma: a study of 7 cases]. | Zhonghua Zhong Liu Za Zhi | 2025 | 40113428 | PubTator, text mining | PubMed |
| TFE3 and HIF1α regulates the expression of SHMT2 isoforms via alternative promoter utilization in ovarian cancer cells. | Cell Death Dis | 2025 | 40097394 | PubTator, text mining | PubMed |
| A Case Report of INI1 Loss and SMARCB1 Mutation in Hereditary Succinate Dehydrogenase-Deficient Renal Cell Carcinoma. | Int J Surg Pathol | 2025 | 40094795 | PubTator, text mining | PubMed |
| Perivascular Epithelioid Cell Tumor of the Lung With a Novel YAP1::TFE3 Fusion. | Int J Surg Pathol | 2025 | 40080865 | PubTator, text mining | PubMed |
| SEVENTH ANNUAL MEDICLINIC MIDDLE EAST RESEARCH CONFERENCE 23 SEPTEMBER 2024. | Medicine (Baltimore) | 2025 | 40068059 | PubTator, text mining | PubMed |
| Isowalsuranolide targets TrxR1/2 and triggers lysosomal biogenesis and autophagy via the p53-TFEB/TFE3 axis. | Sci China Life Sci | 2025 | 40059270 | PubTator, text mining | PubMed |
| Molecular Characterization of TFE3-Rearranged Renal Cell Carcinoma in Children and Adolescents. | Mod Pathol | 2025 | 40057038 | PubTator, text mining | PubMed |
| TFE3 fusion proteins promote the progression of TFE3 rearranged renal cell carcinoma via enhancing chaperone-mediated lipophagy. | Cell Commun Signal | 2025 | 40050998 | PubTator, text mining | PubMed |
| CAMTA1-immunonegative epithelioid hemangioendotheliomas of the liver: a clinicopathological and molecular analysis of seven cases. | Front Oncol | 2025 | 40040722 | PubTator, text mining | PubMed |
| STING-induced noncanonical autophagy regulates endolysosomal homeostasis. | Proc Natl Acad Sci U S A | 2025 | 39982740 | PubTator, text mining | PubMed |
| Varieties of altered TFE3 can occur in MiT-family-related renal cell carcinomas. | Int Urol Nephrol | 2025 | 39966236 | PubTator, text mining | PubMed |
| Protein phosphatase 6 regulates metabolic dysfunction-associated steatohepatitis via the mTORC1 pathway. | J Hepatol | 2025 | 39947331 | PubTator, text mining | PubMed |
| Hepatic epithelioid hemangioendothelioma with TFE3 rearrangement: a case report and literature review. | Front Oncol | 2025 | 39917171 | PubTator, text mining | PubMed |
| Oncogenic TFE3 fusions drive OXPHOS and confer metabolic vulnerabilities in translocation renal cell carcinoma. | Nat Metab | 2025 | 39915638 | PubTator, text mining | PubMed |
| Cytomorphology and clinicopathologic correlation of TFE3-rearranged renal cell carcinoma. | Cancer Cytopathol | 2025 | 39912368 | PubTator, text mining | PubMed |
| Multi-institutional Analysis of Immune-Oncology Combination Therapy for Metastatic MiT Family Translocation Renal Cell Carcinoma. | J Immunother | 2025 | 39901604 | PubTator, text mining | PubMed |
| [Molecularly defined renal cell carcinomas]. | Pathologie (Heidelb) | 2025 | 39870878 | PubTator, text mining | PubMed |
| MAPK1IP1L::TFE3-rearranged renal cell carcinoma: a novel fusion adding to the differential diagnosis of oncocytic renal neoplasms. | Virchows Arch | 2025 | 39862330 | PubTator, text mining | PubMed |
| The Type III Intermediate Filament Protein Peripherin Regulates Lysosomal Degradation Activity and Autophagy. | Int J Mol Sci | 2025 | 39859265 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7030/papers?page=14